Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse

Inflammation Research

Volumn 58, Issue 6, 2009, Pages 312-320

  Zhu, Y G ^a,b   Qu, J M ^a,b  

^a HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Age; IFN ; N protein of SARS CoV; Severe acute respiratory syndrome (SARS); TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; NUCLEOCAPSID PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD SAMPLING; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; LEUKOCYTE COUNT; LUNG EDEMA; LUNG INJURY; MALE; MOUSE; NONHUMAN; PNEUMONIA; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS NUCLEOCAPSID;

AGING; ANIMALS; CHEMOKINES; CYTOKINES; LUNG; MALE; MICE; MICE, INBRED BALB C; NUCLEOCAPSID PROTEINS; PNEUMONIA; PULMONARY EDEMA; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 67649510948     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-8062-9     Document Type: Article

References (33)

1. Li AM, Ng PC. Severe acute respiratory syndrome (SARS) in neonates and Children. Arch Dis Child Fetal Neonatal Ed 2005; 90: 461 -465.
2. Ksiazek TG, Ersman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953-1966.
3. Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, et al. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006; 351: 466-475.
4. Hiscox JA, Wurm T, Wison L, Britton P, Cavanagh D, Brooks G. The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus. J Virol 2001; 75: 506- 512.
5. Collisson EW, Pei J, Dzielawa J, Seo SH. Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry. Dev Comp Immunol 2000; 24: 187-200.
6. Zhu MS, Pan Y, Chen HQ, Shen Y, Wang XC, Sun YJ, et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 2004; 92: 237- 243.
7. Jin K, Chong X, Chen Z, Chen Z, Kang Y, Ma Y, et al. Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Biochem Biophys Res Commun 2005;
8. 979-986.
9. Zhu YJ, Chen WB, eds. Respiratory medicine. Beijing: People's Medical Publishing House; 2003: 1396-1422.
10. Millar AB, Foley NM, Singer M, Johnson NM, Meager A, Rook GA. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989; 2: 712-714.
11. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
12. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360: 1831-1837.
13. Van Reeth K, Van Gucht S, Pensaert M. In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding. Vet Immunol Immunopathol 2002; 87: 161-168.
14. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004; 136: 95-103.
15. Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, et al. Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome. Infect Immun 2004; 72: 4410-4415.
16. Beijing Group of National Research Project for SARS. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin Med J (Engl) 2003; 116; 1283-1287.
17. Ng PC, Lam CW, Li AM, Wong CK, Cheng FW, Leung TF, et al. Inflammatory cytokine Profile in children with severe acute respiratory syndrome. Pediatrics 2004; 113(1 Pt 1): e7-14.
18. Ng PC, Leung CW, Chiu WK, Wong SF, Hon EK. SARS in Newborns and Children. Biol Neonate 2004; 85: 293-298.
19. Liu BH, Wu DL, Zhan DW, Qin ED, Zhu QY Study on the animal model for Severe Acute Respiratory Syndrome. Acta Micro Sinica 2004; 44: 711-716.
20. Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L, et al.A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice. PLoS Pathog 2007; 3: e5.
21. Subbarao K, J McAuliffe, LVogel, G Fahle, S Fischer, K Tatti, et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 2004; 78: 3572- 3577.
22. Hao D, He LX, Qu JM, Pan J, Hu BJ, Zhang J, et al. A study of mechanismofpulmonaryinflammationcausedby SARS-CoVand effects of glucocorticoids on it. Chin J Internal Med 2005; 44: 890- 893.
23. Hon KL, Leung CW, Cheng W, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003; 361: 1701-1703.
24. Leung CW, Kwan YW, Ko PW, et al. Severe acute respiratory syndrome among children. Pediatrics 2004; 113: e535-e543.
25. Roberts A, C Paddock, L Vogel, E Butler, S Zaki, K Subbarao. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol 2005; 79: 5833-5838.
26. Ne LG, Li HC, Jue CL, Wang GF, Ma J, et al. The clinical presentation and treatment of second-peak in SARS. Beijing University Acta 2003; 35: 553-555.
27. Ma J, Li N, Jue CL, Li HC, Ne LG, Wang GF, et al. The character of radiography and dynamic variation in SARS. Beijing University Acta 2003; 35(supp): 38-40.
28. Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58: 686- 689.
29. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003; 9: 1064-1069.
30. Cimolai N, Taylor GP, Mah D, Morrison BJ. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol. 1992; 36: 465-478.
31. American Thoracic Society. Mechanisms and limits of induced postnatal lung growth. Am J Respir Crit Care Med. 2004; 170: 319-343.
32. Thurlbeck WM. Lung growth and alveolar multiplication. Pathobiol Annu. 1975; 5: 1-34.
33. Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol. 2003; 34: 743-748.